INTRODUCTION
Composite lymphoma (CL) is defined as two histologically distinct variants of malignant lymphoma occurring in the same organ or mass.
1,2 CL is quite rare, with frequency ranging from 1 to 4.7% of lymphoma cases. 3 Many combinations of lymphoma types have been reported in CLs, including composite B-cell lymphoma, composite B-and T-cell lymphoma, and composite Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). 2 Previously reported cases of composite HL and NHL were combinations of HL and B-cell non-Hodgkin lymphoma, such as HL and follicular lymphoma (FL), as well as HL and diffuse large B-cell lymphoma. [4] [5] [6] In some cases, polymerase chain reaction (PCR) amplification and sequence analysis of the immunoglobulin heavy chain gene (IGH) demonstrated common clonal origins in the two abovementioned cases, 5, 6 suggesting the clonal relationship in combination HL and NHL.
Several combinations of low grade B-cell lymphoma, including FL and mantle cell lymphoma (MCL), FL and B-chronic lymphocytic leukemia/small lymphocytic lymphoma, and MCL and nodal marginal zone lymphoma (NMZL), have also been reported. [7] [8] [9] Some of these cases showed clonal relation whereas other cases were clonally unrelated. [7] [8] [9] We report a case of CL of FL and CD5-positive NMZL in a lymph node, and demonstrated different B-cell clones in the FL and CD5-positive NMZL.
CASE REPORT
A 72-year-old, Japanese male had been treated for hypertension and suspicion of Parkinson's disease by his family doctor. The patient noticed a mass in the left groin one year prior. The mass was small, and the patient did not have fever or any other symptoms. After 6 months, the size of the mass began to increase. His family doctor then referred him to a hematologist at our hospital, and masses were identified in the left groin, right neck, and left flank. Excisional biopsy of an inguinal lymph node was performed for pathological diagnosis with flow cytometry and karyotype analyses. Peripheral blood evaluation revealed a hemoglobin level of 13.0 g/dL, a platelet count of 13. Minoru Kojima, 2) Kiyoshi Ando, 2) and Naoya Nakamura 
PATHOLOGICAL FINDINGS
Histological evaluation of the resected lymph node demonstrated multiple follicles evenly distributed throughout (Fig. 1) . Most follicles had a reactive-germinal center (GC) with tingible body macrophages, thin mantle zone, and wide marginal zone (Fig. 2) . The wide marginal zone consisted of medium-sized cells having a slightly indented nucleus and clear cytoplasm, indicating monocytoid cells (Fig. 2 ). There were several follicles that had GCs filled with numerous centrocytes ( Figs.1 & 2) . Plasma cell differentiation was unclear in both the wide marginal zone and centrocyte-rich GC.
Immunohistochemically, monocytoid cells in the wide marginal zone were CD3 -, CD5 + , CD10 -, CD20 + , BCL-2 + , BCL-6 -, MUM-1 -and cyclin D1 -, and lymphocytes in the GC (Fig. 2) . Both κ + plasma cells and λ + plasma cells were observed in in situ hybridization, showing no restriction of the light chain.
PCR sequencing of the IGH from microdissected samples of the CD5-positive NMZL and FL showed different sequences in the CDR3 region, with IGHV3-23 in the CD5-positive NMZL and IgHV3-7 in the FL (Fig. 4) .
DISCUSSION
We presented an unusual variation of CL composed of CD10-positive FL and CD5-positive NMZL, which to the best of our knowledge is the first case of such combination. Considering the results from the histological and immunohistochemical analysis, three possibilities were raised; (1) Cases of CL containing a CD5-positive low grade B-lymphoma component have been previously reported. 7, 8, 10 In four of these cases, PCR sequencing of IGH was performed; 7, 8 three of the cases showed common clonal origin and the other case had different clonal origins. Although the progenitor cells of CL containing CD5-positive low grade B-lymphoma with common clonal origin may be lymphoid stem cells or immature B-cells, the latter case and our case may have developed by chance.
MCL and chronic lymphocytic leukemia/small lymphocytic lymphoma are the main components observed in CL, and there has been a previously reported case of CL composed of CD5-positive splenic marginal zone lymphoma and FL with uncertain clonal relationship. 10 Due to the small number of cases, we were unable to determine the factor leading to the pathogenesis of CL composed of CD10-positive FL and CD5-positive low grade B-cell lymphoma, including MZL. Although such cases occur by chance, further accumulation of cases is important for identification of the factors involved in the pathogenesis of CL composed of FL and CD5-positive NMZL, as well as other CL.
In our case, the FL area was small, suggesting possible in situ FL. In situ FL has been recognized by the recent World Health Organization (WHO) classification system, but the incidence rate remains unknown due to the limited number of published cases and series. 11, 12 In situ FL shows preservation of the nodal architecture, and most follicles appear to be cytologically reactive, whereas rare germinal centers appear to be monotonous and lack tingible body macrophages.
11
The later follicles show strongly positive staining for BCL-2 and CD10, whereas the majority of follicles in the same lymph node are negative for BCL-2. In most cases of FL, tumor cells involve the majority of the follicles and infiltrate into the inter-follicular region; however, in in situ FL, tumor cells involve only a few follicles, and do not infiltrate into the many remaining reactive follicles or the inter-follicular region. There is also a possibility of overt FL of the systemic lymph nodes. NMZL is currently defined in the WHO classification as a primary nodal B-cell lymphoma that morphologically resembles extranodal or splenic MZL, but without evidence of extranodal or splenic disease. 13 NMZL is uncommon, accounting for less than 2% of all lymphomas. 13 Generally, NMZL do not express CD5, but a few have been shown to do so. CD5-positive NMZL have histologic and immunophenotypic features typical of NMZL in addition to the expression of CD5. Jaso et al. reported the proportion of CD5-positive NMZL to typical NMZL to be 8.6% (7/91 cases).
14 Of the CD5-positive NMZL patients, 86% (6/7 cases) showed lymphadenopathy above and below the diaphragm, 6 cases underwent bone marrow check, and all cases had bone marrow invasion.
14 In our case, lymphadenopathy above and below the diaphragm was observed, but not bone marrow invasion.
In NMZL, CD5 has been reported to be expressed in only 8.6% cases, and CD5 expression correlates with a higher frequency of dissemination and bone marrow invasion. 14 However, patients with CD5-positive NMZL generally have an indolent clinical course and excellent overall survival. 14 In our case, although bone marrow invasion was not observed, dissemination above and below the diaphragm was present. In CD5-positive NMZL, the mechanism of CD5 expression and progenitor identification remain unclear; however, CD5 expression in NMZL may be associated with wide dissemination.
